Empresa Atrinsic, Inc. Other OTC
Acciones
US04964C2089
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
|
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 01/02/16 |
Andrew Slee
COO | Chief Operating Officer | 74 | 01/04/16 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/02/16 |
Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 03/02/94 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/02/16 |
Brian Corvese
BRD | Director/Board Member | 67 | 28/07/17 |
Khalil Barrage
BRD | Director/Board Member | 59 | 01/07/07 |
Timothy Wright
BRD | Director/Board Member | 66 | 23/11/22 |
Jennifer Buell
BRD | Director/Board Member | 49 | 18/07/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 4 435 132 | 3 466 915 ( 78,17 %) | 0 | 78,17 % |
Información de la empresa
Protagenic Therapeutics, Inc.
149 Fifth Avenue Suite 500
10010, New York
+212 994 8200
http://www.protagenic.com![Dirección Atrinsic, Inc.](https://cdn.zonebourse.com/static/address/9355004.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+38,36 % | 52,73 mil M | |
+39,67 % | 39 mil M | |
-8,63 % | 38,52 mil M | |
+25,46 % | 30,38 mil M | |
-11,17 % | 26,39 mil M | |
+11,44 % | 26,08 mil M | |
+45,09 % | 14,15 mil M | |
+32,93 % | 12,6 mil M | |
-5,30 % | 11,51 mil M |
- Bolsa de valores
- Acciones
- Acción PTIX
- Acción
- Empresa Atrinsic, Inc.